| Laura Marie Baumgart, LCSW | |
|
1390 S 1100 E Ste 204, Salt Lake City, UT 84105-2463 | |
| (734) 306-1279 | |
| Not Available |
| Full Name | Laura Marie Baumgart |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1390 S 1100 E Ste 204, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003428566 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 9539712-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Marie Baumgart, LCSW 5101 E Emigration Canyon Rd, Salt Lake City, UT 84108-1672 Ph: (734) 306-1279 | Laura Marie Baumgart, LCSW 1390 S 1100 E Ste 204, Salt Lake City, UT 84105-2463 Ph: (734) 306-1279 |
News Archive
Execution by lethal injection may cause death by asphyxiation, and prisoners being executed may be conscious and may experience pain, claim the authors of a new study published this week in PLoS Medicine.
DiaGenic ASA today announced a research agreement to collaborate with GE Healthcare to develop a blood-based test using DiaGenic's peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer's Disease.
Nick Chapman, a policy analyst at Policy Cures, writes in a guest post on the Global Health Technologies Coalition's "Breakthroughs" blog about "the results of the latest G-FINDER survey on global funding of [research and development (R&D)] for neglected diseases."
Some research has suggested that omega-3 fatty acids, abundant in fish oils, can relieve inflammation in Crohn's disease. But a new study using software developed by Duke scientists hints that we should be paying closer attention to what the other omegas - namely, omega-6 and omega-7 - are doing to improve or worsen the disease.
Human Genome Sciences, Inc. and Lonza today announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE). BENLYSTA is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in 2006.
› Verified 1 days ago
Mr. Glen Ray Lambert, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1361 Rebecca Cir, Salt Lake City, UT 84117 Phone: 801-272-7742 Fax: 801-322-2831 | |
Mr. Mark Lynn Duke, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 132 South State, Suite 200, Salt Lake City, UT 84111 Phone: 801-240-3556 | |
Kristine Louise Nelson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Va Slc, 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565 | |
Dr. Joel L Millard, DSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 150 E 700 S, Salt Lake City, UT 84111 Phone: 801-364-8080 Fax: 801-364-8098 | |
Matthew Kael Nisson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
Michael Keith Slade, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2872 S Highland Dr, Salt Lake City, UT 84106 Phone: 801-485-8051 |